The global leaderboard of wealth: $1.2 Quadrillion of Assets ranked by Market Cap
In-depth research + analysis available with Pro ($3.99/mo) or Pro Plus ($9.99/mo). Everything else on this page is free.
Article
Article
Article
Article
The CREATE AI Act doesn't pick winners, doesn't burden industry and already has a proven track record — Capitol Hill's most actionable AI legislation.
Bitcoin and Ether open interest fell sharply after $8.35 billion in long liquidations, while ETF outflows, weaker Strategy purchases and declining market depth reduced liquidity.
Bitcoin is close to losing $58,000, and the test below that level is whether the buyer stack that defined the post-ETF bull case still holds. Near $58,522 with an intraday low near $58,135, the market is asking whether anyone will buy in si
Saint-Gobain North America's CEO says the real threat to America's next century isn't a lack of innovation — it's a shortage of skilled workers.
Our founders designed the Constitution to safeguard liberty and property against majoritarian excess—a century of emergencies has steadily eroded it.
As AI lowers the cost of creating and analyzing, companies will not hire less—they will expect more. Certain people will thrive.
Bitcoin price is holding the $59K, Ethereum found what could be the bottom, and MiCA full enforcement just hit with almost no fireworks. The post Crypto News, July 1: Bitcoin Price Holds $59K as Ethereum Stays Steady on MiCA Day Zero appear
Still, new CEO Tan Teck Long promised to hire 600 new relationship managers, as wealth management becomes a growing business for the Singaporean bank.
Crypto users spent years making USDC the default dollar of institutional DeFi trading, lending, and settlement, but Open Standard's new Open USD stablecoin is testing whether the dollars users hold can be repaid. Open Standard says business
BTC bears remain in charge as the asset briefly tumbled to $58,000.
Everything you need to know before you reach the office this morning.
The GLP-1 maker’s latest AI investment targets drug discovery and the future of consumer medicine.
